Opinion | Amid the Covid-19 Pandemic, Not Home for the Holidays

But our secure little pods developed leaks whenever our adult children had responsibilities that exposed them to risk. A daughter who’s a lawyer spent days in hearings at the courthouse where someone was infected. Eliza’s mom, a pastor, is back at church, singing with her congregation. One son, who’s an EMT, now swabs suspected Covid patients at an urgent care center.

Now, as I string Thanksgiving garlands across the mantle and pull the straw pilgrims out of their boxes, I face the depressing reality that no one else will be in our home for the holidays. By Thanksgiving, our Covid bubble will have popped.

Even when it worked, when small pods of us had our groceries delivered and worked from home, the waltzing in and out of each other’s bubbles created stress. When does a leak require a confession?

“Your nanny goes to the college with the Covid outbreak?”

“Are

Read More

The FDA announced emergency approval of the first COVID-19 self-test that can be done fully at home. It provides results in 30 minutes.



a person taking a selfie in a room: Dr. Vincent Carrao swabs a patient's nose for the coronavirus disease (COVID-19) test at Palisades Oral Surgery, in Fort Lee, New Jersey, U.S., June 15, 2020. REUTERS/Brendan McDermid


© REUTERS/Brendan McDermid
Dr. Vincent Carrao swabs a patient’s nose for the coronavirus disease (COVID-19) test at Palisades Oral Surgery, in Fort Lee, New Jersey, U.S., June 15, 2020. REUTERS/Brendan McDermid

  • The Food and Drug Administration (FDA) announced Tuesday the emergency approval of the first COVID-19 test that can be done fully at home.
  • Lucira Health’s COVID-19 nasal swab self-test provides results in 30 minutes or less, and is authorized only on prescription.
  • People over the age of 14 can take the test if their healthcare provider suspects they may have COVID-19, the FDA said. 
  • Stephen M. Hahn, FDA commissioner, said: “While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home.”
  • Visit Business Insider’s homepage for more stories.

The US Food and Drug Administration (FDA) on Tuesday approved the first at-home COVID-19 test kit for emergency

Read More

COVID-19 outbreak at Missouri nursing home leaves 20 dead, over 100 infected

An outbreak of COVID-19 in an eastern Jackson County, Mo., nursing home has reportedly left 20 dead and dozens of residents battling the disease.



a person sitting on a table: coronavirus COVID-19 community spread u.s. centers for disease control and prevention CDC test kits diagnostic 33 percent fail rate failure approved lindstrom stepehen respiratory quality control


© iStock
coronavirus COVID-19 community spread u.s. centers for disease control and prevention CDC test kits diagnostic 33 percent fail rate failure approved lindstrom stepehen respiratory quality control

County health officials report that 157 people at the John Knox Village Care Center have tested positive for COVID-19, and the Kansas City Star reported 20 deaths from the virus occurred at the nursing home.

Seventeen of the deaths occurred this month and three people died last month, the facility’s vice president of health and community services told the newspaper.

“All these folks were somebody’s loved ones, someone’s parents, grandparents, and they really become part of our family as well,” Rodney McBride told the Star. “It’s really been heart wrenching. You just feel like you should have

Read More

The FDA Announced Emergency Approval of the First COVID-19 Self-Test That Can Be Done Fully at Home

It provides results in 30 minutes.

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!


2 min read


This story originally appeared on Business Insider

The US Food and Drug Administration (FDA) on Tuesday approved the first at-home COVID-19 test kit for emergency use.

The COVID-19 All-In-One Test Kit, made by biotech company Lucira Health, is the first nasal swab test that can be fully self-administered at home, and it provides results in 30 minutes or less, according to a statement from the government agency.

Once the patient has done the nasal swab, it is then stirred into a vial and placed in a test unit. Within minutes, lights indicate whether the individual is positive, negative, or needs to repeat the test.

Related: The New Pfizer Vaccine Needs Plenty of Cold Storage, but Will There Be Enough Dry Ice?

The single-use test

Read More

FDA Clears First Covid-19 Test Performed Fully at Home

The U.S. Food and Drug Administration has cleared the first Covid-19 test that people can take at home by themselves and get results without the help of a lab, a long-awaited step.

The single-use, disposable test from Lucira Health Inc. uses nasal swabs and can be self-administered by anyone with a doctor’s prescription ages 14 years or older. The test searches for the genetic material of the new coronavirus and can give results in up to 30 minutes, the company said.

Some Covid-19 tests have been previously authorized for at-home collection, but Lucira’s is the first that can be fully self-performed and provide results at home minutes later.

Public-health experts have been clamoring for fast, easy-to-use at-home Covid-19 testing, especially as the virus is spreading at increasing rates around the U.S. If made widely available and cost-effective, at-home testing could become a valuable tool in helping people to safely return

Read More

U.S. Approves First At-Home Test Kit for Detecting Covid-19

(Bloomberg) — The U.S. gave a greenlight to the first Covid-19 testing kit to be used in the home, adding a new tool to battle the pandemic as nationwide testing capabilities come under more strain.

Loading...

Load Error

The Food and Drug Administration issued an emergency use authorization to Lucira Health Inc.’s rapid-result All-In-One Test Kit, according to a statement from the agency on Tuesday. The kit is expected to cost around $50, the company said, and consumers will need a prescription to acquire it.

While some Covid-19 tests allow people to to mail in samples collected at home, this is the first that can be fully self-administered and provides results at home in 30 minutes or less. The clearance comes at a time when the country — which has the world’s largest number of cases, at more than 11 million — is fighting a fierce resurgence of infections.

Initially, Lucira

Read More

FDA approves first COVID-19 self-test kit fully done at home

  • The Food and Drug Administration (FDA) announced Tuesday the emergency approval of the first COVID-19 test that can be done fully at home.
  • Lucira Health’s COVID-19 nasal swab self-test provides results in 30 minutes or less, and is authorized only on prescription.
  • People over the age of 14 can take the test if their healthcare provider suspects they may have COVID-19, the FDA said. 
  • Stephen M. Hahn, FDA commissioner, said: “While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home.”
  • Visit Business Insider’s homepage for more stories.

The US Food and Drug Administration (FDA) on Tuesday approved the first at-home COVID-19 test kit for emergency use.

The COVID-19 All-In-One Test Kit, made by biotech company Lucira Health, is the first nasal swab test that can be fully self-administered at home, and it provides results in 30

Read More

FDA Authorizes At-Home Covid-19 Test That Gives Results In 30 Minutes

Topline

The U.S. Food and Drug Administration (FDA) on Tuesday issued an emergency use authorization to a Covid-19 self-test that can be used at home and provide results within 30 minutes, marking the FDA’s first such approval in a move that could help expand access to testing in the country.

Key Facts

The single-use testing kit, made by Lucira Health, has been authorized for home use and requires self-collected nasal swab samples in individuals who are 14 or older, the FDA announced in a news release.

The test can be used on children under the age of 14 only when the sample is collected by a healthcare provider in point-of-care settings like hospitals, doctor’s offices and urgent care centers, among other places.

Currently, the test will only be available with a prescription.

The

Read More

Covid-19 News: Live Updates – The New York Times

Here’s what you need to know:

Credit…Lucira Health

The Food and Drug Administration on Tuesday gave an emergency green light to the first rapid coronavirus test that can run from start to finish at home, paving a potential path for more widespread testing outside of health care settings.

The test, developed by the California-based company Lucira Health, requires a prescription from a health care provider. People under the age of 14 also cannot perform the test on themselves. But with a relatively simple nasal swab, the test can return results in about half an hour, and is projected by the company to cost $50 or less, according to the product’s website. Clinicians can also run the test on patients, including children under the age of 14, potentially delivering answers during a single visit to a care

Read More

FDA approves emergency use for first at-home Covid-19 test kit

Covid-19 nasal swab test administered on patient.

Lisa Maree Williams | Getty Images News | Getty Images

The U.S. Food and Drug Administration (FDA) has approved emergency use for the first Covid-19 test that can be conducted entirely at home.

The agency cleared the single-use test, which provides results within 30 minutes, for use by anyone aged 14 and over if their health-care provider suspects they may have Covid-19.

Produced by a privately held, California-based biotech company, Lucira Health, the kit is also eligible for use in hospitals, though patients under 14 must have their sample collected by a health-care provider.

The FDA did not reveal the price of the test. The company’s website says the test is “intended to cost less than $50.”

“While Covid-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner

Read More